tiprankstipranks
Advertisement
Advertisement

TNGX Stock Latest News

Tango Therapeutics Adds Veteran Biopharma Leader to Board
Company AnnouncementsTango Therapeutics Adds Veteran Biopharma Leader to Board
3m ago
8K
TNGX
Tango Therapeutics Announces Major Underwritten Equity Offering
PremiumCompany Announcements
Tango Therapeutics Announces Major Underwritten Equity Offering
13d ago
8K
TNGX
Tango Therapeutics 18.2M share Secondary priced at $30.00
PremiumThe Fly
Tango Therapeutics 18.2M share Secondary priced at $30.00
14d ago
TNGX
Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright
PremiumThe Fly
Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright
14d ago
TNGX
Tango Therapeutics price target raised to $42 from $30 at Canaccord
PremiumThe Fly
Tango Therapeutics price target raised to $42 from $30 at Canaccord
14d ago
TNGX
Tango Therapeutics announces $500M common stock offering
PremiumThe FlyTango Therapeutics announces $500M common stock offering
15d ago
TNGX
Tango Therapeutics price target raised to $69 from $55 at Leerink
Premium
The Fly
Tango Therapeutics price target raised to $69 from $55 at Leerink
15d ago
RVMD
TNGX
Catanzaro Raises TNGX Price Target to $36, Reiterates Buy on Promising Vopimetostat/Daraxonrasib Data in Pancreatic Cancer
Premium
Ratings
Catanzaro Raises TNGX Price Target to $36, Reiterates Buy on Promising Vopimetostat/Daraxonrasib Data in Pancreatic Cancer
15d ago
TNGX
Tango Therapeutics price target raised to $36 from $30 at Mizuho
PremiumThe Fly
Tango Therapeutics price target raised to $36 from $30 at Mizuho
15d ago
TNGX
Midday Fly By: Nvidia partners with SK Hynix, Campbell’s reports Q3 beat
PremiumThe Fly
Midday Fly By: Nvidia partners with SK Hynix, Campbell’s reports Q3 beat
15d ago
CG
CPB
Tango Therapeutics rises 45.5%
PremiumThe Fly
Tango Therapeutics rises 45.5%
15d ago
TNGX
Tango Therapeutics upgraded at Wolfe after ‘impressive’ vopimetsotat combo data
PremiumThe Fly
Tango Therapeutics upgraded at Wolfe after ‘impressive’ vopimetsotat combo data
15d ago
TNGX
Tango Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe FlyTango Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
15d ago
TNGX
Tango Therapeutics price target raised to $35 from $21 at B. Riley
Premium
The Fly
Tango Therapeutics price target raised to $35 from $21 at B. Riley
15d ago
TNGX
Tango Therapeutics rises 32.1%
Premium
The Fly
Tango Therapeutics rises 32.1%
15d ago
TNGX
RBC Capital says Tango-Revolution data strengthens daraxonrasib’s PDAC position
PremiumThe Fly
RBC Capital says Tango-Revolution data strengthens daraxonrasib’s PDAC position
15d ago
RVMD
TNGX
Tango Therapeutics Highlights Promising Vopimetostat Combination Data
PremiumCompany Announcements
Tango Therapeutics Highlights Promising Vopimetostat Combination Data
15d ago
8K
TNGX
Tango Therapeutics announces data from study of vopimetostat, daraxonrasib
PremiumThe Fly
Tango Therapeutics announces data from study of vopimetostat, daraxonrasib
15d ago
RVMD
TNGX
Tango Therapeutics Holds 2026 Virtual Annual Stockholder Meeting
PremiumCompany Announcements
Tango Therapeutics Holds 2026 Virtual Annual Stockholder Meeting
19d ago
8K
TNGX
Tango Therapeutics falls -19.7%
PremiumThe FlyTango Therapeutics falls -19.7%
1M ago
TNGX
Tango Therapeutics falls -14.9%
Premium
The Fly
Tango Therapeutics falls -14.9%
1M ago
TNGX
Tango Therapeutics price target raised to $30 from $20 at Mizuho
Premium
The Fly
Tango Therapeutics price target raised to $30 from $20 at Mizuho
1M ago
TNGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >